Subscribe
shutterstock_298303490_vonaua
VonaUA / Shutterstock.com
24 March 2020AfricaSarah Morgan

US companies hit hardest by fake medicines: EUIPO, OECD

Companies registered in the US are hit hardest by the trade in counterfeit medicines, which in 2016 reached $4.4 billion, according to a report from the  European Union Intellectual Property Office (EUIPO).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Large-scale probe seizes 10.5m fake medicines
20 December 2022   Operation took place across Europe | Criminal networks are still exploiting opportunities offered by the COVID-19 pandemic.
Big Pharma
Fraudsters will invest heavily in fake COVID-19 vaccine: Europol
1 May 2020   Once a genuine vaccine against COVID-19 has been announced, counterfeiters and fraudsters are likely to invest heavily in offering ineffective counterfeit versions of the vaccine online, according to Europol.
Big Pharma
OECD and Europol issue COVID-19 counterfeits warning
22 April 2020   The COVID-19 pandemic is heightening the dangers posed by the global trade in counterfeit pharmaceutical products, according to the OECD and EUIPO.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Big Pharma
Large-scale probe seizes 10.5m fake medicines
20 December 2022   Operation took place across Europe | Criminal networks are still exploiting opportunities offered by the COVID-19 pandemic.
Big Pharma
Fraudsters will invest heavily in fake COVID-19 vaccine: Europol
1 May 2020   Once a genuine vaccine against COVID-19 has been announced, counterfeiters and fraudsters are likely to invest heavily in offering ineffective counterfeit versions of the vaccine online, according to Europol.
Big Pharma
OECD and Europol issue COVID-19 counterfeits warning
22 April 2020   The COVID-19 pandemic is heightening the dangers posed by the global trade in counterfeit pharmaceutical products, according to the OECD and EUIPO.

More on this story

Big Pharma
Large-scale probe seizes 10.5m fake medicines
20 December 2022   Operation took place across Europe | Criminal networks are still exploiting opportunities offered by the COVID-19 pandemic.
Big Pharma
Fraudsters will invest heavily in fake COVID-19 vaccine: Europol
1 May 2020   Once a genuine vaccine against COVID-19 has been announced, counterfeiters and fraudsters are likely to invest heavily in offering ineffective counterfeit versions of the vaccine online, according to Europol.
Big Pharma
OECD and Europol issue COVID-19 counterfeits warning
22 April 2020   The COVID-19 pandemic is heightening the dangers posed by the global trade in counterfeit pharmaceutical products, according to the OECD and EUIPO.

More features

WATCH: The transparency tightrope—balancing innovation, regulation, and IP protection in a new era
Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Powell Gilbert launches Düsseldorf office with leading patent litigator
Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids
Kilpatrick adds ‘seasoned litigator’ as trademark partner
WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond
Startup challenges rival over brain monitoring tech at ITC